Phase 1 and 2 Studies Demonstrate the Safety and Efficacy of Intraprostatic Injection of PRX302 for the Targeted Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia-Reference-Cited by-同舟云学术

Phase 1 and 2 Studies Demonstrate the Safety and Efficacy of Intraprostatic Injection of PRX302 for the Targeted Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia

Published:2011-05 Issue:5 Volume:59 Page:747-754
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Denmeade Samuel R.,Egerdie Blair,Steinhoff Gary,Merchant Rosemina,Abi-Habib Ralph,Pommerville Peter

Publisher

Elsevier BV

Subject

Urology

Reference17 articles.

1. Enlarged prostate: a landmark national survey of its prevalence and impact on US men and their partners;Roehrborn;Prost Canc Prost Dis,2006

2. Benign prostatic hyperplasia: an overview;Roehrborn;Rev Urol,2005

3. epidemiology, and natural history of benign prostatic hyperplasia;Lepor;Rev Urol,2004

4. Efficacy and safety of long-term treatment with the dual 5 alpha-reductase inhibitor dutasteride in men with symptomatic benign prostatic hyperplasia;Debruyne;Eur Urol,2004

5. The evolution of alpha-blockers for the treatment of benign prostatic hyperplasia;Lepor;Rev Urol,2006

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging drugs for the treatment of benign prostatic hyperplasia: a 2023 update;Expert Opinion on Emerging Drugs;2024-06-14

2. Early investigational agents for the treatment of benign prostatic hyperplasia’;Expert Opinion on Investigational Drugs;2024-03-04

3. Minimal-invasive Therapie: Wie ist der Stand im Jahre 2021 – was kommt, was geht;Aktuelle Urologie;2022-03-01

4. Minimal-invasive Therapieoptionen zur Behandlung des benignen Prostatasyndroms;Der Urologe;2021-11-05

5. New Ultra-minimally Invasive Surgical Treatment for Benign Prostatic Hyperplasia: A Systematic Review and Analysis of Comparative Outcomes;European Urology Open Science;2021-11